Literature DB >> 28228272

Commanding CNS Invasion: GM-CSF.

Junjie Zhao1, Lillian Sun2, Xiaoxia Li3.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF or Csf-2) is a pro-inflammatory mediator implicated in the pathogenesis of various autoimmune diseases. In this issue of Immunity, Spath et al. (2017) show that the dysregulated production of GM-CSF rather than IL-17 induces spontaneous immunopathology in a mouse model of CNS inflammation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28228272      PMCID: PMC6172037          DOI: 10.1016/j.immuni.2017.02.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  9 in total

1.  The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

Authors:  Mohamed El-Behi; Bogoljub Ciric; Hong Dai; Yaping Yan; Melissa Cullimore; Farinaz Safavi; Guang-Xian Zhang; Bonnie N Dittel; Abdolmohamad Rostami
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

2.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

Authors:  Laura Codarri; Gabor Gyülvészi; Vinko Tosevski; Lysann Hesske; Adriano Fontana; Laurent Magnenat; Tobias Suter; Burkhard Becher
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

3.  Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.

Authors:  Zizhen Kang; Chenhui Wang; Jarod Zepp; Ling Wu; Kevin Sun; Junjie Zhao; Unni Chandrasekharan; Paul E DiCorleto; Bruce D Trapp; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

4.  Immunology: In the beginning.

Authors:  Richard M Ransohoff
Journal:  Nature       Date:  2009-11-05       Impact factor: 49.962

Review 5.  GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation.

Authors:  Burkhard Becher; Sonia Tugues; Melanie Greter
Journal:  Immunity       Date:  2016-11-15       Impact factor: 31.745

6.  IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Yan Hu; Naruhisa Ota; Ivan Peng; Canio J Refino; Dimitry M Danilenko; Patrick Caplazi; Wenjun Ouyang
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

7.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

Authors:  Zizhen Kang; Cengiz Zubeyir Altuntas; Muhammet Fatih Gulen; Caini Liu; Natalia Giltiay; Hongwei Qin; Liping Liu; Wen Qian; Richard M Ransohoff; Cornelia Bergmann; Stephen Stohlman; Vincent K Tuohy; Xiaoxia Li
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

8.  The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.

Authors:  Andrew L Croxford; Margit Lanzinger; Felix J Hartmann; Bettina Schreiner; Florian Mair; Pawel Pelczar; Björn E Clausen; Steffen Jung; Melanie Greter; Burkhard Becher
Journal:  Immunity       Date:  2015-09-01       Impact factor: 31.745

9.  Fate mapping of IL-17-producing T cells in inflammatory responses.

Authors:  Keiji Hirota; João H Duarte; Marc Veldhoen; Eve Hornsby; Ying Li; Daniel J Cua; Helena Ahlfors; Christoph Wilhelm; Mauro Tolaini; Ursula Menzel; Anna Garefalaki; Alexandre J Potocnik; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

  9 in total
  5 in total

1.  IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier.

Authors:  Sandip Ashok Sonar; Shagufta Shaikh; Nupura Joshi; Ashwini N Atre; Girdhari Lal
Journal:  Immunol Cell Biol       Date:  2017-07-06       Impact factor: 5.126

2.  NFIL3 deficiency alleviates EAE through regulating different immune cell subsets.

Authors:  Zhigang Chen; Rong Fan; Jie Liang; Zexiu Xiao; Junlong Dang; Jun Zhao; Ruihui Weng; Cansheng Zhu; Song Guo Zheng; Ying Jiang
Journal:  J Adv Res       Date:  2021-11-14       Impact factor: 12.822

Review 3.  Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis.

Authors:  Jehan Aram; Anna Francis; Radu Tanasescu; Cris S Constantinescu
Journal:  Neurol Ther       Date:  2018-12-01

Review 4.  Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update.

Authors:  Noushin Lotfi; Rodolfo Thome; Nahid Rezaei; Guang-Xian Zhang; Abbas Rezaei; Abdolmohamad Rostami; Nafiseh Esmaeil
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

5.  Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis.

Authors:  Hélène Salvator; Aristine Cheng; Lindsey B Rosen; Peter R Williamson; John E Bennett; Anuj Kashyap; Li Ding; Kyung J Kwon-Chung; Ho Namkoong; Christa S Zerbe; Steven M Holland
Journal:  Respir Res       Date:  2022-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.